ATS 2018 International Conference - Mobile

Daniel Wachtlin

MSc

Boehringer Ingelheim Pharma GmbH & Co. KG

Session(s)

Investigating the Effect of Nintedanib on Changes in Biomarkers of ECM Turnover in Patient...
Sunday, May 20 11:15 AM - 1:00 PM
Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF)...
Sunday, May 20 11:15 AM - 1:00 PM